Berkeley Lab researchers have developed a new family of nanocarriers, called “3HM,” that meets all the size and stability requirements for effectively delivering therapeutic drugs to the brain for the treatment of a deadly form of cancer known as glioblastoma multiforme.
At the American Chemical Society Meeting in Boston: Berkeley Lab’s Paul Alivisatos and Noah Bronstein Discuss Nanoparticles and Solar Energy Applications
With help from Berkeley Lab’s Advanced Light Source, scientists from UCLA recently designed a cage made of proteins. The nano-sized cage could lead to new biomaterials and new ways to deliver drugs inside cells. It boasts a record breaking 225-angstrom outside diameter, the largest to date for a designed protein assembly. It also has a 130-angstrom-diameter